Furthermore, knockout of the Sphk2 gene reduces leukemia development in a mouse model of acute lymphoblastic leukemia (ALL), and pharmacologic inhibition extends survival of mice in xenograft models of human disease [76]. Here, SPHK2 is linked to acute lymphoblastic leukemia.